News - Page 62 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor

Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor

Post published:February 21, 2023
Post category:Press Release

Read more about the article AIMS v. DEA: Advocating for Open Access to Psilocybin Assisted Therapy

AIMS v. DEA: Advocating for Open Access to Psilocybin Assisted Therapy

Post published:February 21, 2023
Post category:2022 Year in Review

Read more about the article Psychedelic Policy & Law in 2022

Psychedelic Policy & Law in 2022

Post published:February 21, 2023
Post category:2022 Year in Review

Read more about the article Psychedelics Take a Step Towards the Policy Agenda in Czechia

Psychedelics Take a Step Towards the Policy Agenda in Czechia

Post published:February 21, 2023
Post category:2022 Year in Review

Read more about the article The Medical Potential of Psychedelics: A View from the European Union

The Medical Potential of Psychedelics: A View from the European Union

Post published:February 21, 2023
Post category:2022 Year in Review

Read more about the article Psychedelic Bulletin #131: Study Turns Understanding of Psychedelic-Induced Neuroplasticity Inside Out; EU Regulators Show Interest in Psychedelics; What Next for At-Home Ketamine Therapy?

Psychedelic Bulletin #131: Study Turns Understanding of Psychedelic-Induced Neuroplasticity Inside Out; EU Regulators Show Interest in Psychedelics; What Next for At-Home Ketamine Therapy?

Post published:February 20, 2023
Post category:Psychedelic Bulletin

Read more about the article Numinus Expands Research Capabilities with new Phoenix Clinical Research Site

Numinus Expands Research Capabilities with new Phoenix Clinical Research Site

Post published:February 17, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Announces Non-Executive Director Appointment

Bright Minds Biosciences Announces Non-Executive Director Appointment

Post published:February 17, 2023
Post category:Press Release

Read more about the article Pioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity

Pioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity

Post published:February 16, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Provides Update on Phase 1 DMT Clinical Study, Drug Found Safe to Proceed to Next Phase

Algernon NeuroScience Provides Update on Phase 1 DMT Clinical Study, Drug Found Safe to Proceed to Next Phase

Post published:February 16, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.